- Home
- WDC vs NVS Comparison
WDC vs NVS Comparison
Compare WDC & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WDC | NVS |
|---|---|---|
| Founded | 1970 | 1895 |
| Country | United States | Switzerland |
| Employees | N/A | 75267 |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 257.2B | 286.5B |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | WDC | NVS |
|---|---|---|
| Price | $641.57 | $153.38 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 22 | 5 |
| Target Price | ★ $281.77 | $144.00 |
| AVG Volume (30 Days) | ★ 7.3M | 1.7M |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | 0.12% | ★ 2.16% |
| EPS Growth | N/A | N/A |
| EPS | ★ 16.05 | N/A |
| Revenue | ★ $9,520,000,000.00 | N/A |
| Revenue This Year | $32.24 | $2.30 |
| Revenue Next Year | $26.55 | $5.27 |
| P/E Ratio | $41.79 | ★ $23.13 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $62.94 | $112.34 |
| 52 Week High | $799.87 | $170.46 |
Technical Indicators
Market Signals| Indicator | WDC | NVS |
|---|---|---|
| Relative Strength Index (RSI) | 57.05 | 57.83 |
| Support Level | $457.44 | $143.27 |
| Resistance Level | N/A | $154.57 |
| Average True Range (ATR) | 44.54 | 2.32 |
| MACD | 6.41 | 0.38 |
| Stochastic Oscillator | 47.08 | 86.70 |
Price Performance
Historical ComparisonAbout WDC Western Digital Corporation
Western Digital is a leading vertically integrated supplier of hard disk drives. The HDD market is a practical duopoly, with Western Digital and Seagate being the two largest players. Western Digital designs and manufactures its HDDs, with much of the manufacturing and workforce located in Asia. The primary consumers of HDDs are data centers.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.